EAN 2026: MS Copilot shows promise in monitoring disability progression in MS

In the study, MS Copilot Detect scores correlated with the MSFC-4 framework. In the study, MS Copilot Detect scores correlated with the MSFC-4 framework. The smartphone app showed it was able to track certain digital biomarkers in MS patients. Credit: daily_creativity / Shutterstock.com Sanofi/Ad Scientiam presented an interim analysis from the ongoing MS-DETECT (NCT05816122) study, showing that Microsoft (MS) Copilot can monitor disease progression in patients with multiple sclerosis (MS). The MS-DETECT study is a multi-centre trial across the US, Canada, and Europe with 336 patients enrolled. Patients who were enrolled in or participating in another ongoing clinical trial were…

Source: Clinical Trials Arena